Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Marcocci

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|August 7, 2012
Subclinical vitamin D deficiencyLuisella Cianferotti, Claudio Marcocci
Endocrinology and Metabolism Clinics of North America|November 14, 2021
HypercalcemiaClaudio Marcocci, Filomena Cetani
Nature Clinical Practice. Endocrinology & Metabolism|October 24, 2007
Is parathyroidectomy beneficial in patients with mild, asymptomatic primary hyperparathyroidism?Claudio Marcocci, Aldo Pinchera
Advances in Anatomic Pathology|April 25, 2008
Parafibromin as a tool for the diagnosis of parathyroid tumorsClaudio Marcocci, Filomena Cetani
Best Practice & Research. Clinical Endocrinology & Metabolism|May 29, 2012
Treatment of mild, moderate-to-severe and very severe Graves' orbitopathyClaudio Marcocci, Michele Marinò
The New England Journal of Medicine|December 23, 2011
Clinical practice. Primary hyperparathyroidismClaudio Marcocci, Filomena Cetani
Endocrine|February 5, 2013
The use of positron emission tomography with (11)C-methionine in patients with primary hyperparathyroidismFilomena Cetani, Claudio Marcocci
Expert Review of Endocrinology & Metabolism|February 10, 2019
Cinacalcet in the management of primary hyperparathyroidismFilomena Cetani, Claudio Marcocci
Annales D'Endocrinologie|April 29, 2015
Epidemiology, pathogenesis of primary hyperparathyroidism: Current dataClaudio Marcocci, Federica Saponaro
Endocrine Connections|June 23, 2020
TSH suppressive therapy and boneAlessandro Brancatella, Claudio Marcocci
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Best Practice & Research. Clinical Endocrinology & Metabolism|August 7, 2012
Subclinical vitamin D deficiencyLuisella Cianferotti, Claudio Marcocci
Endocrinology and Metabolism Clinics of North America|November 14, 2021
HypercalcemiaClaudio Marcocci, Filomena Cetani
Nature Clinical Practice. Endocrinology & Metabolism|October 24, 2007
Is parathyroidectomy beneficial in patients with mild, asymptomatic primary hyperparathyroidism?Claudio Marcocci, Aldo Pinchera
Advances in Anatomic Pathology|April 25, 2008
Parafibromin as a tool for the diagnosis of parathyroid tumorsClaudio Marcocci, Filomena Cetani
Best Practice & Research. Clinical Endocrinology & Metabolism|May 29, 2012
Treatment of mild, moderate-to-severe and very severe Graves' orbitopathyClaudio Marcocci, Michele Marinò
The New England Journal of Medicine|December 23, 2011
Clinical practice. Primary hyperparathyroidismClaudio Marcocci, Filomena Cetani
Endocrine|February 5, 2013
The use of positron emission tomography with (11)C-methionine in patients with primary hyperparathyroidismFilomena Cetani, Claudio Marcocci
Expert Review of Endocrinology & Metabolism|February 10, 2019
Cinacalcet in the management of primary hyperparathyroidismFilomena Cetani, Claudio Marcocci
Annales D'Endocrinologie|April 29, 2015
Epidemiology, pathogenesis of primary hyperparathyroidism: Current dataClaudio Marcocci, Federica Saponaro
Endocrine Connections|June 23, 2020
TSH suppressive therapy and boneAlessandro Brancatella, Claudio Marcocci
Pageof 21